title: Study of tolerance and acceptance of a high energy density enteral formula in patients coronary unit study
abstract: Objective: The aim of our study was to evaluate the tolerance of enteral formula with high energetic density in patients hospitalized in a coronary care unit requering enteral support for at least five days.
  Methods: Opened, non-comparative, nonrandomized, descriptive study, evaluating the tolerance of enteral formula with high energy density in patients admitted to a coronary care unit.
  Results: 31 patients were included with a mean age of 67.32 ± 13.8 years, 66.7% were male. The average prescribed final volume Nutrison Energy® was 928.5 ± 278.5 mL/day (range: 800-1,500 mL/day). The average duration of enteral nutrition was 11.2 ± 3.2 days. The average calorie intake was 1,392 ± 417 cal/day, with 169.9 ± 50.9 g/day of carbohydrates, 53.8 ± 16.1 g/day of fat and 55.7 ± 16.9 g/day of protein. After administration there was a significant increased levels of transferrin. A total of 3 patients had an episode of diarrhea (9.7%). The number of patients experiencing at least one episode of gastric residue was 5 (16.1%) not forced in any way to withdra wing enteral nutrition, forcing in 2 patients to diminish the nutritional intake volume for 24 hours. During nutritional support, in only 3 patients it was required to decrease the volume made the previous day energy formula. With regard to vomiting, in 1 patient this situation (3.2%) was verified. No patient in the study presented any digestive complications associated with the administration of the enteral nutrition formula. Finally, no adverse events related to the administered formulation were recorded.
  Conclusions: The results show that enteral formula with high energy density is a well-tolerated formula with a very low frequency of gastrointestinal symptoms, which favors compliance.
authors.affiliation: Centro de Investigación de Endocrinología y Nutrición. Facultad de Medicina. Departamento de Endocrinología y Nutrición. Hospital Clínico Universitario. Universidad de Valladolid. Valladolid. dadluis@yahoo.es.
authors.forename: Olatz
authors.initials: O
authors.lastname: Izaola
authors.forename: Beatriz
authors.initials: B
authors.lastname: De la Fuente
authors.forename: Emilia
authors.initials: E
authors.lastname: Gómez Hoyos
authors.forename: Juan José
authors.initials: JJ
authors.lastname: López Gómez
authors.forename: Beatriz
authors.initials: B
authors.lastname: Torres
authors.forename: Ana
authors.initials: A
authors.lastname: Ortola
authors.forename: Daniel A
authors.initials: DA
authors.lastname: De Luis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003327:Coronary Disease / Q000209:etiology* / Q000628:therapy*; D002149:Energy Intake; D004750:Enteral Nutrition / Q000009:adverse effects; D005260:Female; D005526:Food, Formulated / Q000009:adverse effects*; D006757:Hospital Units; D006801:Humans; D008297:Male; D008875:Middle Aged; D014168:Transferrin / Q000032:analysis; D014839:Vomiting / Q000453:epidemiology / Q000209:etiology
chemical_list: D014168:Transferrin